Table 2.
Insufficient Responders (N = 200) | Responders (N = 383) | Total (N = 583) | P Value | |
---|---|---|---|---|
Number of unique preventive† treatment regimens, n (%) | .085 | |||
0 | 60 (33.5) | 141 (40.6) | 201 (38.2) | .112 |
1 | 62 (34.6) | 126 (36.3) | 188 (35.7) | .704 |
2 | 36 (20.1) | 58 (16.7) | 94 (17.9) | .335 |
3+ | 21 (11.7) | 22 (6.3) | 43 (8.2) | .033 |
Number of unique acute treatment regimens, n (%) | .029 | |||
0 | 11 (5.6) | 6 (1.6) | 17 (3.0) | .008 |
1 | 94 (47.7) | 195 (52.4) | 289 (50.8) | .286 |
2 | 49 (24.9) | 105 (28.2) | 154 (27.1) | .392 |
3+ | 43 (21.8) | 66 (17.7) | 109 (19.2) | .239 |
Number of unique triptans, n (%) | .695 | |||
0 | 22 (11.0) | 41 (10.7) | 63 (10.8) | .913 |
1 | 117 (58.5) | 239 (62.4) | 356 (61.1) | .359 |
2 | 47 (23.5) | 84 (21.9) | 131 (22.5) | .667 |
3+ | 14 (7.0) | 19 (5.0) | 33 (5.7) | .312 |
Change in average headache days/month before prescribed an acute treatment vs now, n (%) | .008 | |||
Headache days increased | 33 (17.8) | 43 (11.8) | 76 (13.8) | |
Headache days decreased | 97 (52.4) | 240 (65.9) | 337 (61.4) | |
No change | 55 (29.7) | 81 (22.3) | 136 (24.8) |
All calculations were based on nonmissing values. Bold font in the P values column indicates statistically significant.
Please note: these data are influenced by the inclusion of a 10% oversampling of patients who had failed at least one line of preventive treatment. P values were from chi‐square or Fisher’s exact test.